HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
4-(Bromoacetyl)pyridine hydrobromide
BUTTPARK 37\12-45 · 4-( Bromoacetyl)pyridine · 4-BromoAcetyl Pyridine HBr · 4-(2-BroMo-acetyl)-pyridiniuM · 4-(BROMOACETYL)PYRIDINE HYDROBROMIDE · 2-broMo-1-(pyridin-4-yl)ethanone.HBr · 4-(2-BROMO-ACETYL)-PYRIDINIUM, BROMIDE · 4-(2-Bromoacetyl)pyridine hydrobromide
Identifikatoren & physikalische Daten
| CAS No. | 5349-17-7 |
|---|---|
| Summenformel | C7H7Br2NO |
| Durchschnittliche Molmasse | 280,94 g/mol |
| Monoisotopische Masse | 278,88943804 g/mol |
| SMILES | Br.O=C(CBr)c1ccncc1 |
| InChIKey | RGALBQILADNMKA-UHFFFAOYSA-N |
| PubChem CID | 2776239 |
| EC No. | 621-664-3 |
| DTXSID | DTXSID90379914 |
Chemische & physikalische Eigenschaften
| Polarare Oberfläche (TPSA) | 30 |
|---|---|
| H-Brücken-Donoren | 1 |
| H-Brücken-Akzeptoren | 2 |
| Frei drehbare Bindungen | 2 |
| Schwere Atome | 11 |
| Formalladung | 0 |
| Komplexität | 121 |
| Schmelzpunkt | 194 °C |
| Lagerbedingungen | under inert gas (nitrogen or Argon) at 2–8 °C |
| Aggregatzustand | powder |
| Farbe | Off-white |
| Löslichkeit | Soluble in water. |
| CAS Datenbank | 5349-17-7(CAS DataBase Reference) |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH302 (87.2%): Harmful if swallowed [Warning Acute toxicity, oral]P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 47 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 4 (87.2%) |
| Zollcode | 2933399990 |
| R-Sätze (R) | 36/37/38-22 |
| Gefahrensymbole | Xi,Xn |
| hazard_note | Irritant |
| Sicherheitshinweise (S) | 26-36/37/39-37/39 |
| Gefahrenklasse | 8 |
Anwendungen & Verwendung
Verwenden
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase 4-(Bromoacetyl)pyridine hydrobromide was used to prepare 2-Phenyl-4-(4-pyridyl)imidazole.